We need more empirical studies about the impact of generative AI on our mental health. I dissect one recent study to show ...
One-time infusion of IMA203CD8 PRAME cell therapy in the ongoing Phase 1 dose escalation/dose expansion trial achieved anti-tumor activity in platinum-resistant ovarian cancer and in uterine cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results